Melanoma in Practice: Nurse Conference
26 July 2018
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’. Designed specifically for nurses, the presentations were designed to give nurses a better understanding of the patient experience from detection through to treatment of advanced disease and included updates in the latest areas of research that are changing the way we treat melanoma.
Presentations were given by melanoma specialists in dermatology, pathology, medical oncology, surgery, radiotherapy, physiotherapy, psychology and clinical trials, as well as melanoma survivors and CNCs who are directly involved in melanoma care
Highlights included a presentation from Associate Professor Robyn Saw who discussed the processes of surgical management of melanoma Stages 0-IV and how “understanding the anatomy is essential for diagnosing and treating melanoma”.
A key takeaway from the conference was a presentation by Associate Professor Matteo Carlino. Associate Professor Carlino delved into the system therapy for the treatment of advanced melanoma and notably pointed out how there has been a shift in nurses’ role in melanoma. “It used to be that advanced melanoma nurses worked primarily on palliative care. We're now in a time where nurses are working on survivorship care”, said Associate Professor Carlino, a statement that really resonated with the audience.
We’d like to thank those who attended and engaged with the conference. One attendee said that ‘all the sessions were so informative and the presenters had a real passion for their work’ and we hope that all attendees found it both enjoyable and beneficial.
The presentations from the Nurse Conference will be made available on our free melanoma education portal for healthcare practitioners in the next few weeks. If you’re a nurse, we encourage you to register your interest at www.melanomaeducation.org.au to be the first to know when they become available.
Olivia is using her Ninja star power to shine a spotlight on melanoma prevention - in memory of her dad.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.
Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate.
A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.
All Australians are urged to join the fight against melanoma this summer.
The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research.
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.